Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Hepatitis in thalassemia minor: incidence and evolution].
Libanore M, Montanari P, Bedetti A, Gualandi G, Borgatti L, Gritti FM. Libanore M, et al. Among authors: gualandi g. Boll Ist Sieroter Milan. 1984;63(5):428-32. Boll Ist Sieroter Milan. 1984. PMID: 6442158 Italian.
Interferon alpha-2B and ribavirin in combination for patients with chronic hepatitis C who failed to respond to, or relapsed after, interferon alpha therapy: a randomized trial.
Barbaro G, Di Lorenzo G, Belloni G, Ferrari L, Paiano A, Del Poggio P, Bacca D, Fruttaldo L, Mongiò F, Francavilla R, Scotto G, Grisorio B, Calleri G, Annese M, Barelli A, Rocchetto P, Rizzo G, Gualandi G, Poltronieri I, Barbarini G. Barbaro G, et al. Among authors: gualandi g. Am J Med. 1999 Aug;107(2):112-8. doi: 10.1016/s0002-9343(99)00160-6. Am J Med. 1999. PMID: 10460040 Clinical Trial.
Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals.
Vertuani S, Bazzaro M, Gualandi G, Micheletti F, Marastoni M, Fortini C, Canella A, Marino M, Tomatis R, Traniello S, Gavioli R. Vertuani S, et al. Among authors: gualandi g. Eur J Immunol. 2002 Jan;32(1):144-54. doi: 10.1002/1521-4141(200201)32:1<144::AID-IMMU144>3.0.CO;2-X. Eur J Immunol. 2002. PMID: 11754355 Free article.
How a faecal immunochemical test screening programme changes annual colorectal cancer incidence rates: an Italian intention-to-screen study.
Bucchi L, Mancini S, Baldacchini F, Ravaioli A, Giuliani O, Vattiato R, Zamagni F, Giorgi Rossi P, Campari C, Canuti D, Di Felice E, Sassoli de Bianchi P, Ferretti S, Bertozzi N, Biggeri A, Falcini F; Emilia-Romagna Region Workgroup for Colorectal Screening Evaluation. Bucchi L, et al. Br J Cancer. 2022 Aug;127(3):541-548. doi: 10.1038/s41416-022-01813-7. Epub 2022 Apr 20. Br J Cancer. 2022. PMID: 35444286 Free PMC article.
Effects of Attendance to an Organized Fecal Immunochemical Test Screening Program on the Risk of Colorectal Cancer: An Observational Cohort Study.
Baldacchini F, Bucchi L, Giuliani O, Mancini S, Ravaioli A, Vattiato R, Zamagni F, Giorgi Rossi P, Mangone L, Campari C, Sassatelli R, Trande P, Esposito P, Rossi F, Carrozzi G, Triossi O, Fabbri C, Strocchi E, Giovanardi M, Canuti D, Sassoli de Bianchi P, Ferretti S, Falcini F; Emilia-Romagna Region Workgroup for Colorectal Screening Evaluation. Baldacchini F, et al. Clin Gastroenterol Hepatol. 2022 Oct;20(10):2373-2382. doi: 10.1016/j.cgh.2022.01.053. Epub 2022 Feb 7. Clin Gastroenterol Hepatol. 2022. PMID: 35144023 Free article.
Results of Compliant Participation in Five Rounds of Fecal Immunochemical Test Screening for Colorectal Cancer.
Baldacchini F, Bucchi L, Giuliani O, Mancini S, Ravaioli A, Vattiato R, Giorgi Rossi P, Campari C, Canuti D, Di Felice E, Mezzetti F, Sassoli de Bianchi P, Ferretti S, Falcini F; Emilia-Romagna Region Workgroup for Colorectal Screening Evaluation. Baldacchini F, et al. Clin Gastroenterol Hepatol. 2021 Nov;19(11):2361-2369. doi: 10.1016/j.cgh.2020.08.038. Epub 2020 Aug 20. Clin Gastroenterol Hepatol. 2021. PMID: 32827723
134 results